Physician profile
Matthew Spellman
NPI 1205810520
$12,059.31
in general payments reported to CMS, 2019-2025
52 companies · $2,302 in 2025
The $2,302 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2020: $1,821 · 2021: $1,268 · 2022: $1,629 · 2023: $1,831 · 2024: $2,052 · 2025: $2,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,149 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,149.40 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,462.68 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Karl Storz Endoscopy-America | $1,363.61 | 2019-2021 | |
| Boston Scientific Corporation | $915.59 | 2019-2025 | General - Kidney Stone Disease, Lithovue, Ams 700 |
| Astellas Pharma US INC | $708.47 | 2019-2023 | Xtandi |
| Urogen Pharma, INC. | $596.65 | 2024-2025 | |
| Pfizer INC. | $487.08 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $446.00 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $434.21 | 2021-2024 | Prolaris |
| Procept Biorobotics Corporation | $418.26 | 2024-2025 | Aquabeam System |
| Accord Healthcare, INC. | $415.29 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $349.94 | 2021-2025 | Provenge |
| Tolmar Pharmaceuticals, INC. | $313.63 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $288.25 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Allergan, INC. | $265.86 | 2019-2021 | |
| Abbvie INC. | $265.38 | 2019-2024 | Botox, Lupron Depot |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $250.89 | 2019-2024 | Xyosted |
| Glaxosmithkline, LLC. | $234.85 | 2025 | Nucala |
| Ferring Pharmaceuticals INC. | $233.84 | 2019-2025 | Adstiladrin |
| Teleflex LLC | $213.20 | 2022-2023 | Urolift |
| Neotract INC. | $206.35 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $190.51 | 2019-2025 | |
| Tolmar, INC. | $176.79 | 2023-2024 | |
| Olympus America INC. | $172.60 | 2023 | Itind System, Soltive, Uretero-Reno Videoscope |
| Verity Pharmaceuticals INC. | $140.51 | 2022-2023 | Trelstar |
| Urovant Sciences INC | $119.10 | 2022 | |
| Blue Earth Diagnostics | $110.26 | 2019-2022 | |
| Canon Medical Systems USA, INC. | $108.59 | 2024 | Toshiba Scanner |
| Amgen INC. | $92.34 | 2019-2023 | Xgeva |
| Astrazeneca Pharmaceuticals LP | $92.00 | 2024-2025 | Lynparza, Imfinzi |
| Novartis Pharmaceuticals Corporation | $87.05 | 2023-2025 | |
| C. R. Bard, INC. & Subsidiaries | $84.13 | 2019 | |
| Srs Medical Systems, INC. | $72.39 | 2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Baxter Healthcare | $69.82 | 2022-2023 | Perclot |
| Sun Pharmaceutical Industries INC. | $69.52 | 2021-2025 | Yonsa |
| Genzyme Corporation | $68.75 | 2025 | |
| Laborie Medical Technologies Corp. | $64.98 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Calyxo, INC. | $64.77 | 2025 | Cvac Aspiration System |
| Rochester Medical Corporation | $60.82 | 2022 | |
| Acerus Pharmaceuticals Corporation | $44.55 | 2021-2022 | |
| Halozyme INC | $41.32 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $35.49 | 2023 | Caldolor |
| Myovant Sciences INC. | $32.24 | 2021-2022 | |
| Medtronic, INC. | $31.10 | 2022 | |
| Progenics Pharmaceuticals, INC. | $27.99 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $23.13 | 2025 | Camzyos |
| Immunitybio, INC. | $21.24 | 2025 | |
| Cook Medical LLC | $19.12 | 2019 | |
| Medline Industries LP | $15.08 | 2022 | |
| Medtronic USA, INC. | $14.22 | 2020 | |
| Zyla Life Sciences, INC. | $13.33 | 2019 | |
| Coloplast Corp | $12.90 | 2021 | |
| Cycle Pharmaceuticals INC | $12.64 | 2024 | Tiopronin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Spellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.